On eve of Alzheimer’s drug decision, Congress critiques FDA for Aduhelm review failures
By
Alicia Lasek
Jan 03, 2023
An “atypical review process and corporate greed” factored into the FDA’s approval of Alzheimer’s drug Aduhelm in 2021, congressional investigators say. They recommend sticking to protocol...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
Cannabis-related issues sending more seniors to the ED, study finds
By
Alicia Lasek
Jan 12, 2023
Cannabis-related ED visits for older adults shot up by a whopping 1,800% between 2005 to 2019 in California, investigators say. The state’s experience mirrors national trends.
Sodium selenate found safe in early trial targeting frontotemporal dementia
By
Alicia Lasek
May 18, 2023
An early-stage study has found that sodium selenate is safe and well-tolerated in patients with behavioral variant frontotemporal dementia.
Preventable diseases tied to common, age-related eye condition, study finds
By
Alicia Lasek
Jan 11, 2023
Age-related macular degeneration is linked to two potentially treatable diseases, suggesting new pathways for preventing progression and blindness, investigators say.
Survey: Over half of U.S. nurses attribute burnout to understaffing
By
Alicia Lasek
May 12, 2023
Respondents linked this issue to feelings of overwork, with 71% saying that understaffing is the key reason for poor mental health.
Omicron BA.2 subvariant tied to less severe illness than delta, original omicron
Oct 28, 2022
Mortality rates are lower for omicron BA.2 than for delta variant and early omicron, investigators report.
FDA authorizes omicron-targeting vaccines as preferred COVID booster shots
By
Alicia Lasek
Sep 01, 2022
The FDA has authorized new, bivalent versions of Pfizer’s and Moderna’s COVID-19 vaccines to be used as booster shots. At the same time, the original monovalent versions are no longer authorized as...
Program that diagnosed fractures virtually led to fewer ER visits for LTC residents: study
By
Alicia Lasek
May 14, 2023
A program that enabled virtual diagnosis and on-site fracture care kept 100% of participating LTC residents out of the emergency department and cut the need for clinic visits, a new study reveals.
Treatment patterns, not genetics, drive prostate cancer disparities, study finds
By
Alicia Lasek
May 29, 2023
Prostate cancer, which affects 1 in 11 men aged 70 and older, has some of the largest disparities in outcomes across all cancer types, investigators say.